Skip to main content
. 2021 Sep 16;10(9):1475. doi: 10.3390/antiox10091475

Figure 5.

Figure 5

Cellular viability (%) of APE against normal mouse fibroblast (L929), human colorectal adenocarcinoma (Caco-2), human lung cancer (A549), and human cervix epithelioid carcinoma (HeLa).